Does DIGOXIN Cause Psychomotor hyperactivity? 6 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Psychomotor hyperactivity have been filed in association with DIGOXIN (Digoxin). This represents 0.1% of all adverse event reports for DIGOXIN.
6
Reports of Psychomotor hyperactivity with DIGOXIN
0.1%
of all DIGOXIN reports
0
Deaths
4
Hospitalizations
How Dangerous Is Psychomotor hyperactivity From DIGOXIN?
Of the 6 reports, 4 (66.7%) required hospitalization, and 2 (33.3%) were considered life-threatening.
Is Psychomotor hyperactivity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DIGOXIN. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does DIGOXIN Cause?
Toxicity to various agents (1,371)
Bradycardia (896)
Dyspnoea (762)
Nausea (762)
Vomiting (715)
Acute kidney injury (708)
Fatigue (638)
Dizziness (616)
Diarrhoea (607)
Drug ineffective (568)
What Other Drugs Cause Psychomotor hyperactivity?
METHYLPHENIDATE (617)
QUETIAPINE (412)
ARIPIPRAZOLE (389)
OLANZAPINE (366)
SERTRALINE (288)
MONTELUKAST (282)
RISPERIDONE (277)
LEVETIRACETAM (247)
VENLAFAXINE (214)
LEVOTHYROXINE (211)
Which DIGOXIN Alternatives Have Lower Psychomotor hyperactivity Risk?
DIGOXIN vs DIHYDRALAZINE
DIGOXIN vs DIHYDROCODEINE
DIGOXIN vs DIHYDROERGOTAMINE
DIGOXIN vs DILANTIN
DIGOXIN vs DILANTIN-125